Alliance Pharma Share Price | |
---|---|
Price | 34.80 |
Bid | 34.80 |
Ask | 34.95 |
Change | -0.10 (-0.29%) |
Volume | 154,945 |
Open | 35.75 |
High | 35.75 |
Low | 34.80 |
Prev. Close | 34.90 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £188.06m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 33.70 |
52 Week Low Date | 10-Nov-2023 |
# Trades | 56 |
---|---|
Vol. Sold | 103,049 |
Sold Value | £35.95k |
Vol. Bought | 51,896 |
Bought Value | £18.13k |
PE Ratio | 204.70588 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.859% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 14:30:27 | 34.818 | 111 | Sell* | 34.80 | 34.95 | 38.65 | O Ordinary |
26-Apr-24 | 14:29:05 | 34.8508 | 2,852 | Sell* | 34.80 | 34.95 | 993.94 | O Ordinary |
26-Apr-24 | 14:22:15 | 34.95 | 5 | Buy* | 34.80 | 34.95 | 1.75 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 14:13:23 | 34.903 | 35,000 | Buy* | 34.80 | 34.95 | 12.22k | O Ordinary Non protected portfolio Single protected transaction |
26-Apr-24 | 14:09:27 | 34.818 | 76 | Sell* | 34.80 | 34.95 | 26.46 | O Ordinary |
26-Apr-24 | 14:03:21 | 34.818 | 512 | Sell* | 34.80 | 34.95 | 178.27 | O Ordinary |
26-Apr-24 | 14:02:43 | 34.903 | 20 | Buy* | 34.80 | 34.95 | 6.98 | O Ordinary Non protected portfolio Single protected transaction |
26-Apr-24 | 13:26:10 | 34.824 | 12,622 | Sell* | 34.80 | 35.00 | 4,395 | O Ordinary |
26-Apr-24 | 12:56:16 | 34.976 | 1 | Buy* | 34.80 | 35.00 | 0.35 | O Ordinary |
26-Apr-24 | 12:54:48 | 34.824 | 29 | Sell* | 34.80 | 35.00 | 10.10 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions